Publications & Research

Monitoring Cancer Treatment with PET/CT: Does It Make a Difference?

This review demonstrates that, given that chemotherapy or chemo-radio¬therapy prior to surgical tumor resection only improves survival for a small percentage of patients, PET/CT may also help reduce costs and unnecessary exposure to toxic therapies by helping physicians to efficiently identify patients who will respond to initial therapy.

Click here to read the full study

  • MITA Smart Initiative

    Promoting patient safety and enhancing the quality of medical imaging technology with MITA Smart Standards. Learn More

  • Fluoro Pharma

    Why I Joined MITA – FluoroPharma Medical, Inc.

    Hear from Thomas Tulip, Ph.D, President, FluoroPharma Medical, Inc. on why his organization joined MITA.

    Learn More